Background-High shear force critically regulates platelet adhesion and thrombus formation during ischemic vascular events. To identify genetic factors that influence platelet thrombus formation under high shear stress, we performed a genome-wide association study and confirmatory experiments in human and animal platelets. Methods and Results-Closure times in the shear-dependent platelet function analyzer (PFA)-100 were measured on healthy, nondiabetic European Americans (nϭ125) and blacks (nϭ116). A genome-wide association (PϽ5ϫ10 Ϫ8 ) was identified with 2 single-nucleotide polymorphisms within the SVIL gene (chromosome 10p11.23) in African Americans but not European Americans. Microarray analyses of human platelet RNA demonstrated the presence of SVIL isoform 1 (supervillin) but not muscle-specific isoforms 2 and 3 (archvillin, SmAV). SVIL mRNA levels were associated with SVIL genotypes (PՅ0.02) and were inversely correlated with PFA-100 closure times (PϽ0.04) and platelet volume (PϽ0.02). Leukocyte-depleted platelets contained abundant levels of the Ϸ205-kDa supervillin polypeptide. To assess functionality, mice lacking platelet supervillin were generated and back-crossed onto a C57BL/6 background. Compared with controls, murine platelets lacking supervillin were larger by flow cytometry and confocal microscopy and exhibited enhanced platelet thrombus formation under high-shear but not low-shear conditions. Conclusions-We show for the first time that (1) platelets contain supervillin; (2) platelet thrombus formation in the PFA-100 is associated with human SVIL variants and low SVIL expression; and (3) murine platelets lacking supervillin exhibit enhanced platelet thrombus formation at high shear stress. These data are consistent with an inhibitory role for supervillin in platelet adhesion and arterial thrombosis. (Circulation. 2012;125:2762-2771.) (C.S., S.M.L.). The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/
A rterial thrombosis is a major cause of myocardial infarction (MI) and stroke. Most clinical events occur when an atherosclerotic plaque ruptures to expose subendothelial collagen and von Willebrand factor (VWF). These proteins bind to platelets, triggering primary activation and granule secretion. 1 Secretion of soluble agonists, including ADP, amplifies activation and leads to integrin activation, platelet-platelet aggregation, and occlusive thrombus formation. Platelets play a more prominent role in arterial thrombus formation than in venous thrombosis because the highly specialized initial platelet-VWF interaction is enhanced by shear stress, such as occurs in coronary arteries. 2, 3 
Clinical Perspective on p 2771
Platelet reactivity varies greatly among individuals. This variation exhibits strong heritability in both European Americans (EAs) and African Americans (AAs), 4 which could explain some of the known genetic contribution to the risk of acute MI. 5 Although genetic epidemiology screens have identified loci associated with MI risk, 6 our understanding of causative genes is limited. The use of intermediate phenotypes to identify genes involved in the pathophysiology of arterial thrombosis can yield stronger genetic associations. 7 Genome-wide association studies (GWAS) have led to the discovery of key molecules regulating human disease 8 and have identified genetic variants and novel genes associated with platelet number, platelet volume, and in vitro platelet aggregation. 9, 10 However, no GWAS has identified genes associated with shear stress-dependent platelet function. The platelet function analyzer-100 (PFA-100) measures the time to platelet thrombus formation under a defined shear stress of 1500 s Ϫ1 in whole blood. 11 The assay requires platelet tethering to VWF, firm adhesion to collagen, platelet activation and secretion, and platelet aggregation mediated by VWF and fibrinogen. Abnormal assay results correlate with platelet hyperfunction and hypofunction associated with acute coronary syndromes [12] [13] [14] [15] and bleeding disorders, respectively. 16, 17 The aim of this study was to identify genetic factors that influence platelet reactivity and thrombus formation under high shear stress. We performed a genome-wide screen with the PFA-100 to identify novel gene variants in AAs and EAs. We identified a novel platelet gene, SVIL (encoding the cytoskeletal regulatory protein supervillin), whose expression negatively regulates platelet reactivity and thrombus formation in both humans and mice.
Methods

Subjects and Platelet Phenotyping
The Platelet Genes and Physiology Study was approved by the institutional review boards of Baylor College of Medicine and Thomas Jefferson University, and informed consent was obtained from all volunteers. Healthy donors were recruited between 2000 and 2006 in Houston, TX. Citrated whole blood was used to measure PFA-100 closure times in a collagen-and ADP-impregnated cartridge (hereafter referred to as PFA-100ColA) within 30 minutes of phlebotomy. A platelet aggregation response of Ͻ10% was considered as exposure to antiplatelet agents and reason for exclusion.
Genotyping
Genomic DNA was extracted from leukocyte buffy coats with the Qiagen DNA extraction kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. DNA from AAs was genotyped on the Illumina Hum1M Beadarray. EA DNAs were genotyped on the Illumina Hum550k Beadarray. Because of the lower levels of linkage disequilibrium in African populations, a denser single-nucleotide polymorphism (SNP) microarray was selected to genotype the DNA samples from AA individuals to improve tagging of causal variants.
Statistical Analysis
Quality control was performed before statistical analysis. Subjects were excluded for relatedness to other participants and for failing stringent genotyping quality control. Individual genotypes that failed quality control were also removed (see Methods in the online-only Data Supplement for details). PFA-100ColA closure times were natural log transformed and tested for associations with the use of an additive model within a linear regression framework. All analyses of EA and AA samples were performed separately. The potential confounders age, sex, VWF activity, plasma fibrinogen level, and platelet CD41 level were tested for significance with the use of forward selection, and significant covariates were retained within the model (PϽ0.1). Principal components analysis was also performed on the data with a subset of the SNP markers that are in linkage equilibrium (r 2 Ͻ0.3). 18 To evaluate whether there is inflation of the test statistic due to population substructure/admixture, was estimated both when no principal components analysis components and when 1 through 5 principal components analysis components were included in the linear regression model.
Platelet Gene Expression Analysis
RNA from leukocyte-depleted platelets (LDP) was prepared for gene expression profiling in 29 healthy subjects. LDP was prepared with the use of density centrifugation followed by CD45-positive cell depletion of platelet-rich plasma (PRP). 19 As controls, RNA from PRP and from the CD45 ϩ leukocyte fraction was extracted from 11 and 5 subjects, respectively, with the use of TRIzol (Invitrogen, Carlsbad, CA). Gene expression analysis was performed with the Sentrix BeadChip and BeadStation system from Illumina, Inc (San Diego, CA). 20
Platelet Supervillin Expression and Correlation With PFA-100ColA
LDP RNA was used to validate the SVIL microarray data. 19 Total LDP RNA was reverse transcribed and polymerase chain reaction (PCR) amplified with the use of a sense primer in coding exon 1 and an antisense primer in coding exon 5 of SVIL isoform 1. Immunoblotting of 6% sodium dodecyl sulfate polyacrylamide gel electrophoresis gels was performed with 4 different anti-supervillin antibodies to verify platelet expression. Natural log-transformed mRNA expression data from microarrays were plotted versus PFA-100ColA closure times for the 23 individuals for whom both values were available. Pearson correlation r and P values were calculated with the use of GraphPad Prism software (La Jolla, CA).
Mouse Platelet Phenotyping
Mice lacking Svil were generated and back-crossed 10 times onto a C57BL/6 background. Svil Ϫ/Ϫ and control C57BL/6 mice were maintained by homozygous breeding. Platelet thrombus formation under shear stress was measured with the use of microfluidic flow chambers with immobilized collagen. 21 Blood from 3 wild-type and 3 Svil Ϫ/Ϫ mice was studied. Experiments were performed over 4 different days, with 3 to 4 runs per day (a "run" was defined as data acquisition from platelet deposition in a single flow chamber) for a total of 15 runs per wild-type genotype and 15 runs per Svil Ϫ/Ϫ genotype. P values were computed with a 2-way repeated-measures, linear mixed-effects ANOVA model that accounts for the main effect of genotype using GraphPad Prism.
Flow Cytometry
Whole blood was diluted into Tyrode's buffer containing 1 mmol/L CaCl 2 and stained with fluorescein isothiocyanate-␣-CD41 (BD Pharmingen) or phycoerythrin-␣-glycoprotein (GP)Ib␣ (Emfret Analytics, Würzburg, Germany). After dilution with phosphatebuffered saline, the cells were analyzed on a FACScan.
Immunofluorescence Confocal Microscopy
Platelets adhered to glass slides statically or to collagen-coated coverslips statically or under high shear stress were stained with Alexa-568 phalloidin and ␣-myosin IIA antibodies and imaged with confocal microscopy. Additional details are available in the onlineonly Data Supplement.
Results
SNPs Within SVIL Are Associated With Platelet Function Under Shear Stress
To assess the capacity for platelet thrombus formation under shear stress, PFA-100ColA was used to measure PFA-100 closure times in a cohort of healthy, nondiabetic subjects (Platelet Genes and Physiology Study). For this genetic study, only subjects self-identified as EA or AA were considered. Blood was collected for PFA-100ColA testing on 154 AAs and 157 EAs. The PFA-100ColA closure time data were normally distributed in both groups (not shown). The DNA from each subject was genotyped for 620 901 or 1 070 000 tag SNPs for EAs or AAs, respectively, with the use of the Infinium II platform. Exclusion criteria included nonsteroidal anti-inflammatory drug use, subject relatedness, and failing genotyping quality control (described in Methods and in the online-only Data Supplement). Table 1 summarizes the demographics of the 116 AA and 125 EA subjects who were analyzed.
The PFA-100ColA phenotype was tested for association with each genotype under an additive model. With the use of log-transformed values of the PFA-100ColA phenotype, analysis was performed with the use of linear regression, controlling for sex, age, CD41, and VWF activity in AAs and for sex and VWF activity in EAs. For AAs, age (PϭϷ10 Ϫ2 ), sex (PϭϷ10 Ϫ2 ), CD41 (PϭϷ10 Ϫ2 ), and VWF activity (PϭϷ10 Ϫ9 ) were significant and were retained in the model. For EAs, only sex (PϭϷ10 Ϫ2 ) and VWF activity (PϭϷ10 Ϫ9 ) were significant, and therefore only these covariates were included in the analysis. Principal components analysis components were not included in the analysis because ϭ1.0, indicating no inflation in the test statistic due to population substructure/admixture. Figure 1A shows Manhattan plots for genotype associations with PFA-100ColA closure times, with a prominent "peak" observed in chromosome 10 for AAs. Table 2 lists the SNPs with the 10 lowest P values for AAs. Notably, 4 of these SNPs were clustered within Ϸ21.8 kb of 4 exons within the SVIL gene, which encodes differentially spliced isoforms of supervillin and archvillin. The most significant SNP, rs7070678 (Pϭ3.6ϫ10 Ϫ8 ), which is a synonymous SNP in exon 14 of the SVIL gene, is in linkage disequilibrium with other SNPs within the SVIL gene but not with SNPs in neighboring genes ( Figure 1B) . A second SNP, rs10826650, within the SVIL gene (intron 13) also reached GWAS significance (PϽ5ϫ10 Ϫ8 ). Two additional SNPs (rs7910521, rs10826649) within introns 16 and 17 of the SVIL gene had P values in the order of 10 Ϫ6 . There was no evidence for deviation from the additive model (analyses not shown). The closest other well-annotated genes in this region, LYZL1 (lysozyme-like 1) and KIAA1462, were Ͼ214 kb from the SVIL SNPs listed in Table 2 , and there was no evidence of an association with either of these genes. The clustering of Figure 2 illustrates the SVIL exon structure, the 2 major known mRNAs, and the location of rs7070678, the SNP with the strongest association with PFA-100ColA closure times. SVIL encodes supervillin, which has a broad cell distribution, and 2 archvillin isoforms, which are enriched in muscle. [22] [23] [24] Supervillin forms a high-affinity link between the actin cytoskeleton and the plasma membrane 22 but has not been described in platelets. Because integrin function and rear-rangements of the actin cytoskeleton are a crucial aspect of the platelet adhesive process, 25 we therefore sought to characterize supervillin in platelets.
Supervillin mRNA and Protein Are Present in Human and Mouse Platelets
Platelet RNA expression analysis was performed with LDP RNA samples from 29 healthy subjects. Probes from the 5Ј-most and 3Ј-most exons (Figure 2A ) were readily detectable. However, an RNA signal was not detected for probe ILMN_1659306, which is specific for archvillin and SmAV. Platelet SVIL transcripts are expressed at moderately high levels and are higher than platelet/endothelial cell adhesion molecule-1 but lower than GPIb␣ mRNAs ( Figure I in the online-only Data Supplement). Supervillin transcripts were easily detected in LDP RNA by reverse transcription PCR ( Figure 2B ), validating the microarray data. Figure 2C shows SVIL mRNA levels for LDP, PRP, and CD45 ϩ leukocytes (white blood cells) as box plots.
Western immunoblotting identified supervillin at Ϸ205 kDa in PRP ( Figure 3A ). This polypeptide migrated slightly 
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more quickly than that seen in control A549 cells, and therefore additional antisera were used to confirm platelet supervillin molecular weight and immunoreactivity. The locations of the epitopes recognized by these antibodies are shown in Figure 3B . In addition, because supervillin is present in leukocytes, 26, 27 we also analyzed LDP and leukocyte-enriched buffy coat. With the use of 2 other antibodies, 205-kDa supervillin was again detected in plate- lets, as well as in the megakaryocyte cell line Meg-01, but was not detected in CD45-enriched leukocytes or K562 erythroleukemia cells ( Figure 3C and 3D) . Finally, supervillin was present in mouse platelets ( Figure 3E ). Sequencing of platelet SVIL mRNA reverse transcription PCR products revealed the presence of SVIL isoform 1, as in HeLa cells (not shown).
Supervillin mRNA Levels Correlate With Platelet Function Under Shear Stress, Platelet Size, and the rs7070678 Genotype
Because platelet protein was available from only a few of the 29 subjects used in the platelet RNA expression analysis, we used SVIL mRNA levels to test for a correlation with platelet function. Figure 4A shows that SVIL mRNA levels correlate with PFA-100ColA closure times (Pϭ0.038). Because longer closure times indicate reduced platelet function, these data suggest that SVIL expression may inhibit human platelet thrombus formation under shear stress. A trend was observed for a similar relationship between SVIL mRNA expression and collagen-induced platelet aggregation (Pϭ0.07) but not with ADP-induced platelet aggregation (Pϭ0.23; data not shown). SVIL mRNA levels also correlated negatively with human mean platelet volume (Pϭ0.016) ( Figure 4B ). Because both SVIL SNPs and SVIL transcripts were associated with PFA-100ColA closure times (Figures 1 and 4) , we tested whether SVIL SNPs were associated with SVIL mRNA levels using a recessive model analysis. Figure 4C shows that SVIL expression differed significantly by rs7070678 genotype.
Platelets From Svil-Deficient Mice Form Thrombi Faster Under Shear Stress in Flow Chamber Studies
To further address the role of supervillin in platelet function, we generated mice from BayGenomics ES cells bearing an insertion in the supervillin (Svil) gene ( Figure 5 ). In this mouse, a ␤-galactosidase/neomycin phosphotransferase (␤gal/neo) gene trap inserted into the large intron downstream of the 13th of the 34 coding exons ( Figure 5A ) disrupts expression of all characterized SVIL splice forms (not shown). [22] [23] [24] The location of the insertion was verified by Southern blotting, which showed that a BglII restriction site from the pGT0lxf vector reduced the 11.5-kb BglII fragment including coding exon 13 to 7.2 kb (not shown), and by PCR ( Figure 5B ) with primers specific for either the wild-type or mutated locus ( Figure 5A, arrows) . This insertion destabilizes the message or protein because supervillin is effectively absent from murine Svil Ϫ/Ϫ platelets ( Figure 5C ) and leukocytes (not shown).
To assess the role of supervillin in platelet thrombus formation under shear stress, we analyzed wild-type and Svil Ϫ/Ϫ platelets in microfluidic flow chamber assays on immobilized collagen. 21 No difference was observed under the "venous" flow rate of 400 s Ϫ1 (Figure 6A and 6B ), but Svil Ϫ/Ϫ platelets showed greater deposition (PϽ0.05) under arterial flow rates of 1200 s Ϫ1 (Figure 6C and 6E) . Both percent coverage of the collagen-coated area, indicating platelet adhesion to collagen, and sum intensity, indicating thrombus formation, were affected.
Although there was no difference between wild-type and Svil Ϫ/Ϫ mice in platelet numbers, Svil Ϫ/Ϫ platelets appeared to be larger as measured by both forward scatter in flow cytometry and confocal microscopy (Table 3) , consistent with the relationship in humans ( Figure 4B ). However, these larger platelets did not express correspondingly greater levels of major surface adhesion receptors integrin ␣IIb or GPIb␣ (Table 3) .
Supervillin directly binds F-actin, myosin II heavy chain, filamin, and many other cytoskeletal proteins. 28 -31 To better elucidate the cytoskeletal and structural differences between wild-type and Svil Ϫ/Ϫ platelets, we analyzed F-actin and myosin IIA organization using immunofluorescence confocal microscopy. Although these platelet cytoskeletons are similar in appearance when statically adhered to glass ( Figure 7A and 7B versus 7C and 7D), Svil Ϫ/Ϫ platelets are more highly spread after activation under high shear flow across collagen ( Figure 7E and 7F versus 7G and 7H). The intensity of F-actin staining increases after activation of both types of platelets, as expected given the associated polymerization of actin. 32, 33 
Discussion
Interindividual variation in platelet reactivity contributes to common arterial thrombotic disorders in humans, but there is only a limited understanding of the responsible molecular mechanisms. We screened a cohort of healthy human subjects by genome-wide genotyping for associations with platelet function assessed under shear stress and identified a candidate gene in AAs that was validated using gene expression and platelet physiology approaches. Our major findings were that (1) genetic variants in SVIL were associated with closure times in the PFA-100ColA; (2) platelets contain supervillin and little or no archvillin or SmAV; and (3) low or absent platelet supervillin is associated with enhanced thrombus formation under high shear stress and increased platelet size in both humans and mice.
Growing evidence supports a role for supervillin as a regulator of cytoskeletal-membrane interactions. Among other functions, supervillin increases myosin II contractility, reduces integrin-mediated cell adhesion, and promotes rapid integrin recycling. 34 -36 Our data support an inhibitory role for supervillin in regulating the rapid activation and spreading of platelets during thrombus formation on collagen under shear stress, an important determinant of platelet responsiveness in arterial thrombosis. These results are consistent with supervillin inhibition of spreading and integrin function in other cell types. 37, 38 
Genome-Wide Association Study
The PFA-100 is dependent on shear stress and is relatively "high throughput." We appreciate that some [12] [13] [14] [15] but not all 39, 40 clinical cardiovascular outcome studies have observed associations with PFA-100 results. The lack of an association between PFA-100 results and clinical outcomes may be due to some nonphysiological conditions, such as anticoagulated blood or an absence of vessel wall. It would be ideal to replicate our findings with other assays in humans; however, neither light transmission aggregometry nor impedance aggregometry is performed under conditions considered to apply shear stress to platelets. Our strategy was to use the GWAS as a screen for identifying novel genes associated with shear-dependent platelet reactivity. However, our study differs from prior platelet genomics studies in that our validation approach employed mRNA expression and physiology experiments. Our statistical analysis was strengthened by the ability to adjust for confounders known to affect platelet adhesion (VWF activity) and aggregation (CD41 levels), which were also shown to be significant in the analysis. Two SNPs in SVIL met the threshold for genome-wide significance in AAs, and 2 additional SVIL SNPs were associated with PFA-100ColA closure times, with P values of ϳ10 Ϫ6 . Figure 6 . Enhanced adhesion and thrombus formation in platelets lacking supervillin (SVIL). Whole blood from wild-type (WT; black line) or Svil Ϫ/Ϫ (SVIL; red line) mice was perfused over immobilized collagen at venous (400 s Ϫ1 ) or arterial (1200 s Ϫ1 ) shear conditions. Platelets in whole blood were labeled with AlexaFluor488-labeled antibodies to platelet GPIX before perfusion. A and C, Surface area covered by platelets at indicated time points presented as percentage of coated collagen ϮSEM (nϭ15 for each genotype). B and D, Sum of fluorescence intensity ϮSEM measured at the indicated time points (nϭ15 for each genotype). Experiments shown in A to D were conducted on 4 different days for a total of 15 runs for each genotype. E, Representative images were taken at the designated times during perfusion at arterial (1200 s Ϫ1 ) shear rates. Bars shown in 1-minute images apply to all time points. Flow cytometric comparisons between mice are shown as fold changes (WT/SVIL) to normalize for day-to-day variation in platelets, antibody fluorescence, binding, and acquisition.
The reason for our inability to detect a similarly strong association in EAs is unclear but probably relates to the limited power of a small sample size by typical GWAS standards and the fact that minor allele frequencies were Ϸ20% lower in EAs. Thus, much larger sample sizes might be necessary to detect an association in EAs. Indeed, supplemental data in the genomic analysis by Johnson et al 9 show modest associations (Ϸ10 Ϫ5 ) between SNPs in SVIL and in vitro platelet aggregation in both AAs and EAs.
None of the 5 SVIL SNPs associated with PFA-100ColA closure times were predicted to affect the protein coding sequence, and therefore we had no reason to suspect that any of these SNPs directly altered supervillin function. This is not unusual because GWAS uses indirect association mapping with tag SNPs that are in linkage disequilibrium with causal variants. 8 However, despite a small sample size composed of both EAs and AAs in our RNA expression study, expression quantitative trait loci analysis supported an association between these SNPs and SVIL mRNA levels ( Figure 4C ). Thus, at least 1 genetic mechanism by which SVIL variants may regulate platelet reactivity is by altering SVIL expression, perhaps via effects on transcription or mRNA stability.
SVIL Expression in Platelets
SVIL mRNA was detected in platelets with the use of a 3ЈUTR probe that recognizes all SVIL transcripts and a 5ЈUTR probe specific for nonmuscle supervillin (Figure 2 ). Archvillin mRNAs were not detected in our microarray expression study, consistent with prior data indicating that archvillin and SmAV are mainly expressed in muscle. 23 In addition to the RNA data, immunoblotting with multiple antibodies demonstrated the presence of abundant supervillin protein in platelets. Using microarray analysis, Watkins et al 27 reported that SVIL mRNA is expressed in multiple hematopoietic cell types including CD4 ϩ and CD8 ϩ T cells, CD14 ϩ monocytes, CD19 ϩ B cells, CD56 ϩ natural killer cells, and CD66b ϩ granulocytes. We also observed SVIL mRNA in CD45 ϩ cells ( Figure 2C) ; found supervillin protein in murine thymocytes, splenocytes, macrophages, and neutrophils by immunoblotting; and recovered Coomassie bluestaining amounts of supervillin from bovine neutrophils. 26 Although high levels of proteases may have caused degradation in human leukocyte lysates (Figure 3) , supervillin is clearly expressed at moderately high levels in platelets ( Figures 2C and 3 and Figure I in the online-only Data Supplement). In addition, because PRP has some contamination with white blood cells, our gene expression data suggest that SVIL mRNA is expressed at higher levels in platelets than in white blood cells ( Figure 2C ). The basis for the reproducibly faster migration of platelet supervillin, compared with HeLa and A549 cell supervillin (Figure 3) , is unclear because the predicted mRNAs are identical. A likely explanation is a cell type-specific difference in posttranslational modifications.
Supervillin and Platelet Size
Supervillin expression levels are inversely correlated with platelet size in both humans and mice. Although Svil Ϫ/Ϫ platelets are larger, they do not have greater surface expression of several critical adhesive glycoproteins (GPIb␣ or integrin ␣ IIb ), suggesting a possible membrane cytoskeletal defect rather than premature release of larger platelets from megakaryocytes. There are several possible mechanisms by which supervillin might regulate platelet size. Filamin anchors the GPIb-IX-V complex to the platelet cytoskeleton and binds to supervillin 31, 41 ; an altered filamin-GPIb␣ interaction could produce larger platelets, such as those characteristic of inherited mutations in the gene encoding GPIb␣. 42, 43 Other possible mechanisms include altered myosin II function similar to the MYH9-associated macrothrombocytopenias 44 or a simple disruption of the actin cytoskeleton that maintains normal platelet size, as in the Wiskott-Aldrich syndrome. 45 The increased platelet size may enhance thrombus formation because high platelet volumes have been associated with MI. 16 
Supervillin and Platelet Function
Supervillin effects on platelet function are most prominent under shear stress. Healthy human subjects expressing higher levels of SVIL mRNA exhibit slower platelet thrombus formation in the PFA-100ColA. Platelets in blood from supervillin-deficient mice form thrombi faster under high shear rates in flow chamber studies than is observed for platelets with wild-type Svil (Figure 6 ). Although the effect of supervillin on platelet adhesion is not dramatic, it is difficult to demonstrate gain-of-function effects, and the increased adhesion observed in Svil-null platelets is well in agreement with other mouse mutants of signaling molecules that limit platelet activation. 37, 38 The mice used in these studies have Svil defects in all tissues, and we cannot exclude an indirect effect on platelets. However, the SVIL association studies used here and by Johnson et al 9 utilized an in vitro platelet assay consisting only of platelets and plasma (ie, aggregometry). Taken together, our results strongly suggest an inhibitory role for supervillin in platelet function.
An inhibitory effect during spreading is consistent with the larger surface profiles observed for supervillin-deficient platelets on collagen after 2 minutes of flow under high shear stress (Figure 7) . The direction of this effect is consistent with a number of mechanisms. First, the larger initial volumes of unactivated Svil Ϫ/Ϫ platelets ( Table 3 ) may contribute to their larger surface areas after activation. Second, the loss of supervillin could increase the rate of cell spreading by increasing integrin adhesion to the substrate or by decreasing myosin II-mediated slowing of the cell spreading rate, as observed in other cell types. 34, 35 Finally, decreased integrity of the membrane-cytoskeleton connection could increase the apparent cross-sectional surface area if Svil Ϫ/Ϫ platelets are more sensitive to cortical disruption by high shear forces. Further studies are needed to determine which supervillin interactions regulate the early phases of platelet activation and adhesion under high-shear forces.
There are potential clinical implications to our findings. If confirmed in additional studies, these data suggest that SVIL variants may contribute to predisposition to cardiovascular disease in AAs. Targeting supervillin in a manner that would enhance its activity might have antithrombotic benefit for arterial vascular diseases such as MI and stroke, a benefit that may be more pronounced in AAs. Conversely, drugs that interrupt supervillin function in platelets could have untoward effects of promoting thrombosis. Finally, SNPs in strong linkage disequilibrium with the causative SVIL variant may be useful as a biomarker for risk of thrombosis or hemorrhage.
Summary
Combined genome-wide technologies in a cohort with wellcharacterized platelet function have led to the identification of a novel protein in platelet biology. We have identified a candidate gene meeting GWAS significance, and both human and mouse studies support an inhibitory effect of supervillin in platelet thrombus formation under shear stress. Although the causative variant in SVIL has not been identified, these data indicate that genetic variations in SVIL expression contribute to variations in human platelet reactivity and support a role for supervillin in arterial thrombosis. Further analysis of SVIL variants may lead to a better understanding of the genetic basis for susceptibility to arterial thrombosis.
